project id: TCGA-THCA; case submitter id: TCGA-EL-A3CW; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.4; age at index: 87; days to birth: -31934; days to death: 938; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1913; year of death: 2004; age at diagnosis: 31934; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2000; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4171; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-EL-A3CW-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0;